Accelerating innovation through collaboration
We believe collaboration is fundamental to advancing the cell and gene therapy industry, enabling us to overcome complex manufacturing challenges and help bring life-changing therapies to patients more quickly.
At Tozaro, we work with purification companies, biopharmaceutical companies, CDMOs, technology providers and academic researchers to develop next-generation purification solutions. Whether you’re looking to optimise an existing process or solve a unique purification challenge, we’d love to explore how we can work together.
Why collaborate with Tozaro?
Collaborating with Tozaro provides access to both our Smart Polymer™ Platform and our expertise in affinity ligand development. Working with us gives you access to:
- The Smart Polymer™ Platform for the rapid design of highly selective affinity ligands.
- Flexible collaboration models, from early feasibility studies through to long-term commercial partnerships.
- Rapid technology development, using computational ligand design, machine learning and scalable chemical manufacturing.
- A collaborative development approach, working closely with your technical team
to deliver solutions tailored to your application.
Collaboration opportunities
We support a range of partnership models depending on your objectives, including:
- Integration of lentiviral vector and AAV affinity ligands into novel affinity chromatography products
- Custom discovery of affinity ligands to novel lentiviral vector pseudotypes and highly engineered AAV capsids
- Smart Polymer ligand discovery to biological or antibody targets lacking established affinity purification method
If your project doesn’t fit neatly into one of these categories, we’d still be pleased to discuss it.
Viral vector collaborations
Our first commercial focus is viral vector purification, where we are collaborating with leading technology providers to accelerate the availability of next-generation affinity purification solutions. Our Smart Polymer™ ligands are being integrated into commercially relevant purification formats, including membranes, monoliths and chromatography resins, enabling improved downstream processing solutions for both lentiviral vectors and AAV.
By partnering with established manufacturers, we aim to make innovative purification technologies available through the workflows and formats already trusted by the industry.
Platform collaborations
While our initial commercial products focus on viral vector purification, the Smart Polymer™ Platform has far broader potential. Our computational design platform enables the rapid development of bespoke affinity ligands for a wide range of bioprocessing applications, including:
- Recombinant protein purification
- Complex antibody purification
- Carrier protein purification
- Viral vaccine manufacturing
- DNA and RNA capture
- New therapeutic modalities requiring selective affinity capture
How to collaborate with us
Whether you’re developing a new therapeutic, improving an existing downstream process or creating an entirely new bioprocessing technology, we’d be delighted to discuss how the Smart Polymer™ Platform could support your project.
Every collaboration begins with a conversation. We’ll take the time to understand your objectives, assess the technical challenge and explore the most appropriate collaboration model to help achieve your goals.
Interested in exploring a collaboration? Contact our team to arrange an introductory discussion and discover how Tozaro can help accelerate your next innovation.